aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · IEX Real-Time Price · USD
1.650
-0.120 (-6.78%)
At close: Jun 18, 2024, 4:00 PM
1.690
+0.040 (2.42%)
After-hours: Jun 18, 2024, 7:15 PM EDT
aTyr Pharma Market Cap
aTyr Pharma has a market cap or net worth of $113.87 million as of June 18, 2024. Its market cap has decreased by -4.63% in one year.
Market Cap
113.87M
Enterprise Value
40.28M
1-Year Change
-4.63%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since May 7, 2015, aTyr Pharma's market cap has decreased from $337.10M to $113.87M, a decrease of -66.22%. That is a compound annual growth rate of -11.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 17, 2024 | 122.10M | -3.33% |
Jun 14, 2024 | 126.30M | -1.10% |
Jun 13, 2024 | 127.70M | -2.59% |
Jun 12, 2024 | 131.10M | -2.60% |
Jun 11, 2024 | 134.60M | 1.05% |
Jun 10, 2024 | 133.20M | -2.49% |
Jun 7, 2024 | 136.60M | 6.39% |
Jun 6, 2024 | 128.40M | 2.23% |
Jun 5, 2024 | 125.60M | -4.20% |
Jun 4, 2024 | 131.10M | 2.66% |
Jun 3, 2024 | 127.70M | 6.95% |
May 31, 2024 | 119.40M | -1.73% |
May 30, 2024 | 121.50M | 4.83% |
May 29, 2024 | 115.90M | -6.15% |
May 28, 2024 | 123.50M | -0.56% |
May 24, 2024 | 124.20M | - |
May 23, 2024 | 124.20M | -3.27% |
May 22, 2024 | 128.40M | -4.61% |
May 21, 2024 | 134.60M | -5.81% |
May 20, 2024 | 142.90M | 3.55% |
May 17, 2024 | 138.00M | 3.60% |
May 16, 2024 | 133.20M | 0.76% |
May 15, 2024 | 132.20M | 5.25% |
May 14, 2024 | 125.60M | 7.08% |
May 13, 2024 | 117.30M | 0.60% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Electromed | 124.64M |
Nuvectis Pharma | 122.80M |
Corvus Pharmaceuticals | 122.60M |
Conduit Pharmaceuticals | 122.19M |
Gossamer Bio | 121.41M |
Veru Inc. | 118.88M |
Karyopharm Therapeutics | 118.35M |
Seres Therapeutics | 117.87M |